New hope for hepatitis b: experimental drug Tune-401 enters human testing
NCT ID NCT06671093
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This early-stage study tests a new drug, Tune-401, in 36 adults with chronic hepatitis B who are already on standard antiviral therapy. The main goal is to check the drug's safety and how the body processes it. Researchers hope Tune-401 may help control the virus better, but this is a first step to see if it is safe enough to study further.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research
RECRUITINGAuckland, 1010, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit
RECRUITINGChisinau, MD2025, Moldova
Contact
-
Queen Mary Hospital, University of Hong Kong
RECRUITINGHong Kong, Hong Kong
Contact
Contact
Conditions
Explore the condition pages connected to this study.